13 results
Keyword regkirona Remove keyword
Categories
Human Remove Human filter
Type of content
News Remove News filter
-
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 August 2023
PRAC, Last updated: 01/09/2023 -
List item
News: EMA annual report 2022 published
Last updated: 15/05/2023 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13 - 16 March 2023
PRAC, Last updated: 17/03/2023 -
List item
News: ETF warns that monoclonal antibodies may not be effective against emerging strains of SARS-CoV-2
Last updated: 09/12/2022tixagevimab / cilgavimab), Regkirona (regdanvimab), Ronapreve … https://www.ema.europa.eu/documents/overview/xevudy-epar-medicine-overview_en.pdf 4: Regkirona EPAR Regkirona | European Medicines Agency … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 August – 1 September 2022
PRAC, Last updated: 02/09/2022 -
List item
News: EMA publishes annual report 2021
Last updated: 10/06/2022 -
List item
News: EMA adopts first list of critical medicines for COVID-19
Last updated: 08/06/2022 -
List item
News: Human medicines: highlights of 2021
Last updated: 15/02/2022Vaccine Janssen Nuvaxovid Regkirona Ronapreve Spikevax Vaxzevria Xevudy Covid-19 Hukyndra Icatibant … -
List item
News: COVID-19: EMA recommends authorisation of antibody medicine Xevudy
CHMP, Last updated: 16/12/2021and follows the approval of Regkirona and Ronapreve in November … -
List item
News: COVID-19: EMA recommends authorisation of two monoclonal antibody medicines
CHMP, Last updated: 12/11/202111/11/2021 Ronapreve and Regkirona are now authorised in the … casirivimab/imdevimab) and Regkirona (regdanvimab) for COVID-19 … Registration GmbH. With regard to Regkirona, the Committee recommended … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 November 2021
CHMP, Last updated: 12/11/2021Regkirona … -
List item
News: EMA receives application for marketing authorisation for Regkirona (regdanvimab) for treating patients with COVID-19
CHMP, PDCO, PRAC, Last updated: 04/10/2021marketing authorisation for Regkirona (regdanvimab) for treating … marketing authorisation for Regkirona (regdanvimab) for treating … -
List item
News: EMA issues advice on use of regdanvimab for treating COVID-19
CHMP, Last updated: 26/03/2021UNAUTHORISED PRODUCT Regkirona (regdanvimab) AVAILABLE … medicinal product for Use: Regkirona Active substance(s …